Modulating Effect of the -158 γ (C→T) Xmn1 Polymorphism in Indian Sickle Cell Patients
- PMID: 22348183
- PMCID: PMC3279316
- DOI: 10.4084/MJHID.2012.001
Modulating Effect of the -158 γ (C→T) Xmn1 Polymorphism in Indian Sickle Cell Patients
Abstract
Xmn1 polymorphism is a known factor, which increases fetal haemoglobin production. Among the inherited disorders of blood, thalassaemia and Sickle Cell Diseases contributes to a major bulk of genetic diseases in India. Our aim was to verify the role of the Xmn1 polymorphism as a modulating factor in sickle cell patients and frequency of the polymorphism in Indian sickle cell patients. 60 sickle homozygous and 75 sickle beta thalassemia patients were included and 5 ml blood sample was collected from them. Screening of sickle patients was done by HPLC. An automated cell analyzer SYSMEX (K-4500 Model) was used to analyze the Complete Blood Count of patients. Xmn1 polymorphism analysis was done by PCR-RFLP and one-way ANOVA test was applied to analysis of variance between groups. Among the sickle patients 27 were heterozygous (+/-) and 19 were homozygous (+/+) while 30 were heterozygous (+/-) and 24 were homozygous (+/+) in sickle β-thalassemia patients. Extremely significant differences (p-value <0.001) of hematological parameters seen among patients with Xmn1 carrier and without the Xmn1 carrier. In our cases the clinical symptoms were barely visible and higher HbF level with Xmn1 carriers were found. Presence of Xmn1 polymorphism in sickle cell patients with higher HbF were phenotypically distinguished in the sickle cell patients. We conclude that the phenotypes of Indian sickle cell patients were greatly influenced by Xmn1polymorphism.
Similar articles
-
A study on the genotype frequency of -158 Gγ (C→T) Xmn1 polymorphism in a sickle cell trait cohort from Siwa Oasis, Egypt.J Genet. 2018 Jun;97(2):505-511. J Genet. 2018. PMID: 29932071
-
Xmn1-G γ polymorphism and clinical predictors of severity of disease in β-thalassemia intermedia.Pediatr Blood Cancer. 2011 Dec 1;57(6):1025-8. doi: 10.1002/pbc.23175. Epub 2011 Jul 13. Pediatr Blood Cancer. 2011. PMID: 21755589
-
Association Between Selected Single Nucleotide Polymorphisms in Globin and Related Genes and Response to Hydroxyurea Therapy in Ghanaian Children with Sickle Cell Disease.Pharmgenomics Pers Med. 2022 Mar 10;15:205-214. doi: 10.2147/PGPM.S351599. eCollection 2022. Pharmgenomics Pers Med. 2022. PMID: 35300055 Free PMC article.
-
Discovering the genetics underlying foetal haemoglobin production in adults.Br J Haematol. 2009 May;145(4):455-67. doi: 10.1111/j.1365-2141.2009.07650.x. Epub 2008 Mar 2. Br J Haematol. 2009. PMID: 19344402 Review.
-
Genetic Modifiers of Fetal Haemoglobin in Sickle Cell Disease.Mol Diagn Ther. 2019 Apr;23(2):235-244. doi: 10.1007/s40291-018-0370-8. Mol Diagn Ther. 2019. PMID: 30478714 Review.
Cited by
-
Fetal haemoglobin induction in sickle cell disease.Br J Haematol. 2018 Jan;180(2):189-200. doi: 10.1111/bjh.15021. Epub 2017 Nov 16. Br J Haematol. 2018. PMID: 29143315 Free PMC article. Review.
-
Hydroxyurea for reducing blood transfusion in non-transfusion dependent beta thalassaemias.Cochrane Database Syst Rev. 2016 Oct 18;10(10):CD011579. doi: 10.1002/14651858.CD011579.pub2. Cochrane Database Syst Rev. 2016. PMID: 27755646 Free PMC article.
-
Genetic modifiers of fetal hemoglobin affect the course of sickle cell disease in patients treated with hydroxyurea.Haematologica. 2022 Jul 1;107(7):1577-1588. doi: 10.3324/haematol.2021.278952. Haematologica. 2022. PMID: 34706496 Free PMC article.
-
Genetic Variation and Sickle Cell Disease Severity: A Systematic Review and Meta-Analysis.JAMA Netw Open. 2023 Oct 2;6(10):e2337484. doi: 10.1001/jamanetworkopen.2023.37484. JAMA Netw Open. 2023. PMID: 37851445 Free PMC article.
-
Association of Xmn1 -158 γG variant with severity and HbF levels in β-thalassemia major and sickle cell anaemia.Mol Biol Rep. 2014 May;41(5):3331-7. doi: 10.1007/s11033-014-3195-5. Epub 2014 Feb 2. Mol Biol Rep. 2014. PMID: 24488321
References
-
- Garner C, Tatu T, Game L, Cardon LR, Spector TD, Farrall M, et al. A candidate gene study of F cell levels in sibling pairs using a joint linkage and association analysis. GeneScreen. 2000;1:9–14. doi: 10.1046/j.1466-9218.2000.00001.x. - DOI
-
- Thein SL, Wainscoat JS, Sampietro M, Old JM, Cappellini D, Fiorelli G, et al. Association of thalassaemia intermedia with a β-globin gene haplotype. Br JHaematol. 1987;65:367–73. - PubMed
-
- Labie D, Pagnier J, Lapoumeroulie C, Rouabhi F, Dunda-Belkhodja O, Chardin P, et al. Common haplotype dependency of high G y-globin gene expression and high Hb F levels in β thalassemia and sickle cell anemia patients. Proc Natl Acad Sci USA. 1985;82:2111–4. doi: 10.1073/pnas.82.7.2111. - DOI - PMC - PubMed